Beer et al: Synovial Fluid C-Reactive Protein as a Biomarker in Osteoarthritis, Immune-Mediated Polyarthritis and Bacterial Infective Arthritis
Veterinary and Comparative Orthopaedics and Traumatology 3, 2026

Synovial Fluid C-Reactive Protein as a Biomarker in Osteoarthritis, Immune-Mediated Polyarthritis and Bacterial Infective Arthritis

🔍 Key Findings

  • Synovial CRP was significantly lower in osteoarthritis than both IMPA and bacterial infective arthritis (p=0.001 for both comparisons).
  • Synovial CRP could not differentiate IMPA from bacterial infective arthritis (p=0.721), limiting its value as a stand-alone diagnostic test.
  • Median synovial CRP concentrations were 0.2 mg/L (OA), 65.79 mg/L (IMPA), and 60.8 mg/L (infective arthritis).
  • Synovial CRP is useful for distinguishing inflammatory from non-inflammatory arthropathies, but not infectious from sterile inflammatory disease.
  • Synovial neutrophil count positively correlated with synovial CRP in IMPA and infective arthritis, supporting CRP as a marker of joint inflammation.
  • Serum and synovial CRP showed a moderate positive correlation in IMPA cases (r=0.52), although not statistically significant.
  • Higher synovial CRP was associated with increased lameness severity in osteoarthritis (r=0.91, p=0.004).
  • Diagnosis of bacterial infective arthritis remains multifactorial, requiring integration of history, cytology, culture, and treatment response rather than CRP alone.

Simini Surgery Review Podcast

How critical is this paper for crushing the Boards?

🚨 Must-know. I’d bet on seeing this.

📚 Useful background, not must-know.

💤 Skip it. Doubt it’ll ever show up.

Thanks for the feedback!
We'll keep fine-tuning the articles vault.
Oops — didn’t go through.
Mind trying that again?

Beer et al: Synovial Fluid C-Reactive Protein as a Biomarker in Osteoarthritis, Immune-Mediated Polyarthritis and Bacterial Infective Arthritis
Veterinary and Comparative Orthopaedics and Traumatology 3, 2026

🔍 Key Findings

  • Synovial CRP was significantly lower in osteoarthritis than both IMPA and bacterial infective arthritis (p=0.001 for both comparisons).
  • Synovial CRP could not differentiate IMPA from bacterial infective arthritis (p=0.721), limiting its value as a stand-alone diagnostic test.
  • Median synovial CRP concentrations were 0.2 mg/L (OA), 65.79 mg/L (IMPA), and 60.8 mg/L (infective arthritis).
  • Synovial CRP is useful for distinguishing inflammatory from non-inflammatory arthropathies, but not infectious from sterile inflammatory disease.
  • Synovial neutrophil count positively correlated with synovial CRP in IMPA and infective arthritis, supporting CRP as a marker of joint inflammation.
  • Serum and synovial CRP showed a moderate positive correlation in IMPA cases (r=0.52), although not statistically significant.
  • Higher synovial CRP was associated with increased lameness severity in osteoarthritis (r=0.91, p=0.004).
  • Diagnosis of bacterial infective arthritis remains multifactorial, requiring integration of history, cytology, culture, and treatment response rather than CRP alone.

Simini Surgery Review Podcast

Know What Matters in the Literature - and Why

We distill peer-reviewed surgical studies into clinically relevant summaries and
exam-style questions, so you can make informed decisions with confidence.

Free Access. No Spam. Just Smarter Surgical Learning

Multiple Choice Questions on this study

In Beer 2026 et al., on synovial CRP biomarkers, which finding best described synovial CRP concentrations among disease groups?

A. Synovial CRP was highest in osteoarthritis
B. Synovial CRP differentiated IMPA from infective arthritis
C. Synovial CRP was significantly lower in osteoarthritis than both IMPA and infective arthritis
D. Synovial CRP was identical in all groups
E. Synovial CRP was lower in infective arthritis than osteoarthritis

Answer: Synovial CRP was significantly lower in osteoarthritis than both IMPA and infective arthritis

Explanation: Synovial CRP distinguished inflammatory from non-inflammatory arthropathies but not specific inflammatory causes.
In Beer 2026 et al., on synovial CRP biomarkers, which diagnostic approach did the authors recommend for suspected bacterial infective arthritis?

A. Rely solely on synovial CRP measurement
B. Use serum CRP alone
C. Base diagnosis only on culture results
D. Integrate history, cytology, culture findings, and treatment response
E. Use radiographs without arthrocentesis

Answer: Integrate history, cytology, culture findings, and treatment response

Explanation: The authors concluded that bacterial infective arthritis remains challenging to diagnose and requires multiple complementary diagnostic factors.
In Beer 2026 et al., on synovial CRP biomarkers, which clinical variable showed a significant positive correlation with synovial CRP concentration in osteoarthritis cases?

A. Age
B. Body weight
C. Lameness severity
D. Duration of disease
E. Neutrophil percentage

Answer: Lameness severity

Explanation: Lameness severity was strongly positively correlated with synovial CRP in osteoarthritis (r=0.91, p=0.004).
In Beer 2026 et al., on synovial CRP biomarkers, what was the median synovial CRP concentration reported in dogs with osteoarthritis?

A. 0.2 mg/L
B. 6.5 mg/L
C. 15 mg/L
D. 60.8 mg/L
E. 65.79 mg/L

Answer: 0.2 mg/L

Explanation: Dogs with osteoarthritis had markedly lower synovial CRP concentrations than inflammatory arthropathy groups.
In Beer 2026 et al., on synovial CRP biomarkers, what was the major limitation of synovial CRP as a diagnostic test?

A. It could not distinguish osteoarthritis from inflammatory arthropathy
B. It could not distinguish IMPA from bacterial infective arthritis
C. It was lower in all inflammatory diseases
D. It correlated negatively with neutrophil count
E. It was unrelated to disease activity

Answer: It could not distinguish IMPA from bacterial infective arthritis

Explanation: Synovial CRP values overlapped substantially between IMPA and infective arthritis cases (p=0.721).

Access the full library of surgical summaries and exam-style questions.

Educational content developed independently and supported by Simini.

The maker of Simini Protect Lavage.

Something off with this article?
Tell us what needs fixing—drop your note below.
Thanks for flagging this!
We’ll review your note as soon as possible.
Oops! Something went wrong while submitting the form.
Anything to add to this article?
Know a finding or detail we missed? Share it below.
Thanks for the suggestion!
We’ll review it as soon as possible.
Oops! Something went wrong while submitting the form.